{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:52:31Z","timestamp":1761562351230,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.carrev.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T14:03:03Z","timestamp":1532095383000},"page":"80-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The ORBITA trial: Why is it not the last nail for coronary angioplasty in stable angina patients?"],"prefix":"10.1016","volume":"20","author":[{"given":"Alfredo E.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10115","key":"10.1016\/j.carrev.2018.07.018_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomise percutaneous coronary intervention in stable angina (ORBITA): a doubleblind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"10115","key":"10.1016\/j.carrev.2018.07.018_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a doubleblind, randomised controlled trial","volume":"391","author":"l-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.carrev.2018.07.018_bb0015","first-page":"81","article-title":"Second versus first drug eluting stents in complex lesions subsets: 3\u202fyears follow up of ERACI IV study","volume":"65","author":"Rodriguez","year":"2017","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.carrev.2018.07.018_bb0020","first-page":"1","article-title":"Can we improve the outcomes of multivessel disease using modified SYNTAX and residual SYNTAX scores?","volume":"20","author":"Rodriguez","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.carrev.2018.07.018_bb0025","first-page":"0012","article-title":"New cobalt chromium stent design in the treatment of real world coronary artery disease: rationality and study design of the all comers observational, multicenter and prospective WALTZ Registry","volume":"1","author":"Mieres","year":"2017","journal-title":"Rev Argent Cardiol"},{"issue":"Feb","key":"10.1016\/j.carrev.2018.07.018_bb0030","article-title":"Lowering risk score profile during PCI in multiple vessel disease is associated with low adverse events: the ERACI risk score","volume":"13","author":"Rodriguez","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"issue":"7","key":"10.1016\/j.carrev.2018.07.018_bb0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.carrev.2015.07.001","article-title":"Modifying angiographic syntax score according to PCI strategy: lessons learnt from ERACI IV study","volume":"16","author":"Rodriguez","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"issue":"42","key":"10.1016\/j.carrev.2018.07.018_bb0040","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1093\/eurheartj\/ehx512","article-title":"Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study","volume":"38","author":"Escaned","year":"2017","journal-title":"Eur Heart J"},{"year":"2018","series-title":"Continues to surprise: 85% of Sham arm opted for PCI when trial ended. Controversies in interventional cardiology I: interventional management in stable coronary artery disease. Presented at: SCAI","author":"ORBITA","key":"10.1016\/j.carrev.2018.07.018_bb0045"},{"key":"10.1016\/j.carrev.2018.07.018_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM199201023260102","article-title":"A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans A\u2013airs ACME Investigators","volume":"236","author":"Parisi","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2018.07.018_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","volume":"350","year":"1997","journal-title":"Lancet"},{"issue":"50","key":"10.1016\/j.carrev.2018.07.018_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009113","article-title":"Utility and quality-adjusted life-years in coronary artery disease: five-year follow-up of the MASS II trial","volume":"96","author":"Brand\u00e3o","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.carrev.2018.07.018_bb0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.117.031907","volume":"137","author":"Fearon","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carrev.2018.07.018_bb0070","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.66.3.562","article-title":"Survival of medically treated patients in the coronary artery surgery study (CASS) registry","volume":"66","author":"Mock","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.07.018_bb0075","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1067\/mhj.2001.116481","article-title":"A validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort","volume":"142","author":"Graham","year":"2006","journal-title":"Am Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918303178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918303178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:14:14Z","timestamp":1761560054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838918303178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1553838918303178"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2018.07.018","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ORBITA trial: Why is it not the last nail for coronary angioplasty in stable angina patients?","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}